Contrast Media Market Is Projected To Grow At A CAGR Of 4.1% by 2032

The global contrast media market is projected to grow at a CAGR of 4.1% for next ten years, jumping from an estimated market value of US$ 5,672 Million in 2022 to US$ 8,447 Million by 2032.

Demand for contrast media has heightened as a result of an increase in the number of installations of the aforementioned devices in healthcare set-ups. Other factors that has given the contrast media market good growth traction include an increase in the frequency of injuries, increase in the number of radiology procedures using contrast media, increase in elderly population, and also the heightened number of diagnostic imaging centers. These attributes have ensured a compound annual growth rate of 4.3% in sale of contrast media over 2017-2021.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=7624?PJ

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐂𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐌𝐞𝐝𝐢𝐚 𝐌𝐚𝐫𝐤𝐞𝐭:

Technological Advancements: The contrast media market is witnessing continuous advancements in imaging technologies and contrast agents. Manufacturers are focusing on developing safer, more effective, and targeted contrast agents to improve diagnostic accuracy and patient safety.

Rising Prevalence of Chronic Diseases: The increasing incidence of chronic diseases, such as cardiovascular diseases, cancer, and neurological disorders, is driving the demand for diagnostic imaging procedures. Contrast media aids in better disease visualization and early detection, contributing to the market's growth.

Growing Aging Population: The global aging population is driving the demand for imaging procedures, particularly for age-related conditions. As elderly individuals are more prone to chronic diseases, there is a parallel increase in the use of contrast media for diagnostic purposes.

Surging Demand for Minimally Invasive Procedures: The shift towards minimally invasive procedures is bolstering the use of contrast media in image-guided interventions. These procedures offer reduced risk, faster recovery times, and better patient outcomes.

Increased Investment in Research and Development: Pharmaceutical companies are investing heavily in research and development to introduce novel contrast agents with enhanced properties, improved safety profiles, and a reduced risk of adverse reactions.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The prominent players operating in the contrast media market are Guerbet, Trivitron Healthcare, Bracco Diagnostic Inc., Nano Therapeutics Pvt. Ltd., Lantheus Medical Imaging Inc., General Electric Company, Daiichi Sankyo Co., Ltd., Spago Nanomedical AB, FUJIFILM Corporation, AMAG Pharmaceuticals, SANOCHEMIA Pharmazeutika AG.

These companies on the contrast media market primarily rely on the introduction of new products based on cutting-edge technological developments, as well as on strategic expansion initiatives like mergers and acquisitions, partnerships, and collaborations.

• In December 2021, GE Healthcare Completes Acquisition of BK Medical. This will help the company in expanding its ultrasound portfolio into surgical visualization.

Fact.MR has provided detailed information about the price points of key manufacturers of contrast media positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬:

Advancements in Medical Imaging: The rapid development of medical imaging technologies, such as CT, MRI, and ultrasound, has significantly increased the demand for contrast media. These technologies offer non-invasive and detailed visualization of anatomical structures, necessitating the use of contrast agents to improve image quality.

Rising Chronic Disease Burden: The prevalence of chronic diseases, including cancer, cardiovascular diseases, and kidney disorders, is on the rise globally. Accurate diagnosis and disease staging, facilitated by contrast media-enhanced imaging, are vital for effective treatment planning.

Increasing Awareness and Adoption: Growing awareness among patients and healthcare providers about the benefits of contrast-enhanced imaging is boosting the market's adoption. Early detection of diseases and improved treatment outcomes are driving the preference for contrast media usage.

Favorable Reimbursement Policies: Government initiatives and favorable reimbursement policies for diagnostic imaging procedures, including those involving contrast media, are propelling market growth.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐂𝐨𝐧𝐭𝐫𝐚𝐬𝐭 𝐌𝐞𝐝𝐢𝐚 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

• By Type :
• Barium-based
• Iodinated
• Gadolinium-based
• Microbubble

• By Imaging Modality :
• X-ray/Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Ultrasound

• By Application :
• Radiology
• Interventional Radiology
• Interventional Cardiology

• By End-user :
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers

• By Region :
• North America
• Latin America
• Europe
• East Asia
• South Asia & ASEAN
• Oceania
• MEA

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:- https://www.factmr.com/connectus/sample?flag=RC&rep_id=7624?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.